40539711000001105: Entecavir 500microgram tablets (Fresenius Kabi Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Entecavir 500microgram tablets (Fresenius Kabi Ltd)
\UK product\Virtual medicinal product\Product containing precisely entecavir 500 microgram/1 each conventional release oral tablet\Entecavir 500microgram tablets (Fresenius Kabi Ltd)
\UK product\Virtual therapeutic moiety\Entecavir\Product containing only entecavir in oral dose form (medicinal product form)\Product containing precisely entecavir 500 microgram/1 each conventional release oral tablet\Entecavir 500microgram tablets (Fresenius Kabi Ltd)
\UK product\Virtual therapeutic moiety\Entecavir\Product containing precisely entecavir 500 microgram/1 each conventional release oral tablet\Entecavir 500microgram tablets (Fresenius Kabi Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing entecavir\Entecavir\Product containing only entecavir in oral dose form (medicinal product form)\Product containing precisely entecavir 500 microgram/1 each conventional release oral tablet\Entecavir 500microgram tablets (Fresenius Kabi Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing entecavir\Entecavir\Product containing precisely entecavir 500 microgram/1 each conventional release oral tablet\Entecavir 500microgram tablets (Fresenius Kabi Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing entecavir\Product containing entecavir in oral dose form (medicinal product form)\Product containing only entecavir in oral dose form (medicinal product form)\Product containing precisely entecavir 500 microgram/1 each conventional release oral tablet\Entecavir 500microgram tablets (Fresenius Kabi Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing purine and/or purine derivative (product)\Product containing guanine nucleoside analog\Product containing entecavir\Entecavir\Product containing only entecavir in oral dose form (medicinal product form)\Product containing precisely entecavir 500 microgram/1 each conventional release oral tablet\Entecavir 500microgram tablets (Fresenius Kabi Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing purine and/or purine derivative (product)\Product containing guanine nucleoside analog\Product containing entecavir\Entecavir\Product containing precisely entecavir 500 microgram/1 each conventional release oral tablet\Entecavir 500microgram tablets (Fresenius Kabi Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing purine and/or purine derivative (product)\Product containing guanine nucleoside analog\Product containing entecavir\Product containing entecavir in oral dose form (medicinal product form)\Product containing only entecavir in oral dose form (medicinal product form)\Product containing precisely entecavir 500 microgram/1 each conventional release oral tablet\Entecavir 500microgram tablets (Fresenius Kabi Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nucleoside analog\Product containing guanine nucleoside analog\Product containing entecavir\Entecavir\Product containing only entecavir in oral dose form (medicinal product form)\Product containing precisely entecavir 500 microgram/1 each conventional release oral tablet\Entecavir 500microgram tablets (Fresenius Kabi Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nucleoside analog\Product containing guanine nucleoside analog\Product containing entecavir\Entecavir\Product containing precisely entecavir 500 microgram/1 each conventional release oral tablet\Entecavir 500microgram tablets (Fresenius Kabi Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nucleoside analog\Product containing guanine nucleoside analog\Product containing entecavir\Product containing entecavir in oral dose form (medicinal product form)\Product containing only entecavir in oral dose form (medicinal product form)\Product containing precisely entecavir 500 microgram/1 each conventional release oral tablet\Entecavir 500microgram tablets (Fresenius Kabi Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Product containing entecavir\Entecavir\Product containing only entecavir in oral dose form (medicinal product form)\Product containing precisely entecavir 500 microgram/1 each conventional release oral tablet\Entecavir 500microgram tablets (Fresenius Kabi Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Product containing entecavir\Entecavir\Product containing precisely entecavir 500 microgram/1 each conventional release oral tablet\Entecavir 500microgram tablets (Fresenius Kabi Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Product containing entecavir\Product containing entecavir in oral dose form (medicinal product form)\Product containing only entecavir in oral dose form (medicinal product form)\Product containing precisely entecavir 500 microgram/1 each conventional release oral tablet\Entecavir 500microgram tablets (Fresenius Kabi Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing entecavir in oral dose form (medicinal product form)\Product containing only entecavir in oral dose form (medicinal product form)\Product containing precisely entecavir 500 microgram/1 each conventional release oral tablet\Entecavir 500microgram tablets (Fresenius Kabi Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Mar 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

2198681000001110 Entecavir 500microgram tablets (Fresenius Kabi Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2198691000001112 Entecavir 500microgram tablets (Fresenius Kabi Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Entecavir 500microgram tablets (Fresenius Kabi Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Entecavir 500microgram tablets (Fresenius Kabi Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Entecavir 500microgram tablets (Fresenius Kabi Ltd)	Is a	Product containing precisely entecavir 500 microgram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Entecavir 500microgram tablets (Fresenius Kabi Ltd)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
Entecavir 500microgram tablets (Fresenius Kabi Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Entecavir 500microgram tablets (Fresenius Kabi Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Entecavir 500microgram tablets (Fresenius Kabi Ltd)	Has specific active ingredient	Entecavir monohydrate	true	Inferred relationship	Existential restriction modifier
Entecavir 500microgram tablets (Fresenius Kabi Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Entecavir	true	Inferred relationship	Existential restriction modifier
Entecavir 500microgram tablets (Fresenius Kabi Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Entecavir 500microgram tablets (Fresenius Kabi Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Entecavir 500microgram tablets (Fresenius Kabi Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Entecavir 500microgram tablets (Fresenius Kabi Ltd) 30 tablet	Has AMP	True	Entecavir 500microgram tablets (Fresenius Kabi Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2198681000001110	Entecavir 500microgram tablets (Fresenius Kabi Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
2198691000001112	Entecavir 500microgram tablets (Fresenius Kabi Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module